Programmed death‐ligand 1 immunoexpression in matched biopsy and liquid‐based cytology samples of advanced stage non‐small cell lung carcinomas
Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) is essential in patients of advanced non-small-cell lung cancer to determine eligibility for immunotherapy. PD-L1 IHC assays have been clinically validated only on formalin-fixed paraffin-embedded tissue; however, lung cancer is frequently...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
2018
|
| Online Erişim: | https://doi.org/10.1111/cyt.12605 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cyt.12605 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|